Does AMIVANTAMAB Cause Renal impairment? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Renal impairment have been filed in association with AMIVANTAMAB (Rybrevant). This represents 0.7% of all adverse event reports for AMIVANTAMAB.
5
Reports of Renal impairment with AMIVANTAMAB
0.7%
of all AMIVANTAMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Renal impairment From AMIVANTAMAB?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Renal impairment Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIVANTAMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does AMIVANTAMAB Cause?
Infusion related reaction (62)
Rash (61)
Pulmonary embolism (41)
Dermatitis acneiform (34)
Thrombocytopenia (33)
Paronychia (29)
Diarrhoea (25)
Pneumonitis (24)
Dyspnoea (23)
Nausea (23)
What Other Drugs Cause Renal impairment?
LENALIDOMIDE (2,161)
EMTRICITABINE\TENOFOVIR DISOPROXIL (2,128)
TACROLIMUS (2,124)
OMEPRAZOLE (2,075)
LANSOPRAZOLE (2,063)
METHOTREXATE (1,852)
ESOMEPRAZOLE (1,811)
PANTOPRAZOLE (1,713)
SACUBITRIL\VALSARTAN (1,610)
CYCLOSPORINE (1,489)
Which AMIVANTAMAB Alternatives Have Lower Renal impairment Risk?
AMIVANTAMAB vs AMIVANTAMAB-VMJW
AMIVANTAMAB vs AMLODIPINE
AMIVANTAMAB vs AMLODIPINE BESILATE
AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB vs AMLODIPINE\BENAZEPRIL